 |
R-4-amino-3-(4-chlorophenyl)butanoic acid |
|---|---|
| Trade Name | |
| Orphan Indication | Fragile X syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2008-11-28 00:00:00 |
| Sponsor | Clinical Research Associates, LLC;160 Fifth Avenue, 7th Floor;New York, New York, 10010 |
